Rabeprazole
Rabeprazole comes in 17 pill versions in our database, in 2 strengths, from 10 manufacturers. Check the imprint to tell them apart.
Rabeprazole pill images
10 mg 5 pills
- ACX 10mg Rabeprazole Sodium 10 mg White & yellow, capsule, 10 mm Used for acid reflux (GERD) and heartburn
- R10 Rabeprazole Sodium 10 mg Pink, round Used for acid reflux (GERD) and heartburn
- R10 Rabeprazole Sodium 10 mg Pink, round Used for acid reflux (GERD) and heartburn
- R10 Rabeprazole Sodium 10 mg Pink, round Used for acid reflux (GERD) and heartburn
- No picture yet DIN 02243796 Rabeprazole Sodium 10 mg Pariet, Enteric-Coated Tablet 10 mg, Tablet (enteric-coated), sold in Canada Used for acid reflux (GERD) and heartburn
20 mg 12 pills
- ACIPHEX 20 Rabeprazole Sodium 20 mg Yellow, round, 8 mm Used for acid reflux (GERD) and heartburn
- AR Rabeprazole 20 mg Yellow, round, 7 mm Used for acid reflux (GERD) and heartburn
- KU 7 Rabeprazole Sodium 20 mg Blue, round, 7 mm Used for acid reflux (GERD) and heartburn
- L020 Rabeprazole Sodium 20 mg Yellow, round, 7 mm Used for acid reflux (GERD) and heartburn
- 107 Rabeprazole Sodium 20 mg Yellow, round, 7 mm Used for acid reflux (GERD) and heartburn
- B683 Rabeprazole Sodium 20 mg Yellow, round, 8 mm Used for acid reflux (GERD) and heartburn
- Y70 Rabeprazole Sodium 20 mg Yellow, round, 8 mm Used for acid reflux (GERD) and heartburn
- 20 Rabeprazole Sodium 20 mg Yellow, round, 8 mm Used for acid reflux (GERD) and heartburn
- No picture yet DIN 02243797 Rabeprazole Sodium 20 mg Pariet, Enteric-Coated Tablet 20 mg, Tablet (enteric-coated), sold in Canada Used for acid reflux (GERD) and heartburn
- No picture yet DIN 02314185 Rabeprazole Sodium 20 mg Sandoz Rabeprazole, Tablet (enteric-coated), sold in Canada Used for acid reflux (GERD) and heartburn
- No picture yet DIN 02356538 Rabeprazole Sodium 20 mg Rabeprazole EC, Tablet (enteric-coated), sold in Canada Used for acid reflux (GERD) and heartburn
- No picture yet DIN 02385457 Rabeprazole Sodium 20 mg Rabeprazole, Tablet (enteric-coated), sold in Canada Used for acid reflux (GERD) and heartburn
What is Rabeprazole used for?
Rabeprazole is used for acid reflux (GERD), heartburn, ulcers and H. pylori infection.
- Medicine type
- Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label
Healing of Erosive or Ulcerative GERD in Adults
Rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD). For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium delayed-release tablets may be considered.
Maintenance of Healing of Erosive or Ulcerative GERD in Adults
Rabeprazole sodium delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (GERD Maintenance). Controlled studies do not extend beyond 12 months.
Treatment of Symptomatic GERD in Adults
Rabeprazole sodium delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with GERD in adults for up to 4 weeks.
Healing of Duodenal Ulcers in Adults
Rabeprazole sodium delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers. Most patients heal within four weeks.
Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence in Adults
Rabeprazole sodium delayed-release tablets, in combination with amoxicillin and clarithromycin as a three drug regimen, are indicated for the treatment of patients with H. pyloriinfection and duodenal ulcer disease (active or history within the past 5 years) to eradicate H. pylori. Eradication of H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.
In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted.
Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome in Adults
Rabeprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Treatment of Symptomatic GERD in Adolescent Patients 12 Years of Age and Older
Rabeprazole sodium delayed-release tablets are indicated for the treatment of symptomatic GERD in adolescents 12 years of age and above for up to 8 weeks.
From the FDA-approved label on DailyMed (published Sep 29, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.